Evaluating immunity to <scp>SARS‐CoV</scp> ‐2 in nursing home residents using saliva <scp>IgG</scp>-Reference-Cited by-同舟云学术

Evaluating immunity to SARS‐CoV ‐2 in nursing home residents using saliva IgG

Published:2022-01-22 Issue:3 Volume:70 Page:659-668
ISSN:0002-8614
Container-title:Journal of the American Geriatrics Society
language:en
Short-container-title:J American Geriatrics Society

Author:

Katz Morgan J.¹^ORCID,Heaney Christopher D.²,Pisanic Nora³,Smith Leigh¹,Bigelow Benjamin F.⁴,Sheikh Fatima⁵,Boudreau Alec¹,Kruczynski Kate²^ORCID,Hsu Yea‐Jen⁶,Salinas Alejandra B.¹,Cosgrove Sara E.¹,Rock Clare¹

Affiliation:

1. Division of Infectious Diseases, Department of Medicine Johns Hopkins University School of Medicine Baltimore Maryland USA

2. Department of Environmental Health and Engineering Epidemiology and International Health Johns Hopkins Bloomberg School of Public Health Baltimore Maryland USA

3. Department of Environmental Health and Engineering Johns Hopkins Bloomberg School of Public Health Baltimore Maryland USA

4. Johns Hopkins Medicine COVID Testing The Johns Hopkins Medical Institutions Baltimore Maryland USA

5. Division of Geriatric Medicine and Gerontology, Department of Medicine Johns Hopkins University School of Medicine Baltimore Maryland USA

6. Department of Health Policy and Management Johns Hopkins Bloomberg School of Public Health Baltimore Maryland USA

Funder

Centers for Disease Control and Prevention

Publisher

Wiley

Subject

Geriatrics and Gerontology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgs.17660

Reference24 articles.

1. Nursing home Covid‐19 data dashboard;National Healthcare Safety Network;Centers for Disease Control,2020

2. CuriskisA KellyC KissaneE andOehlerK.What We Know—and What We Don't Know—About the Impact of the Pandemic on Our Most Vulnerable Community. The COVID Tracking Project March 31st 2021. Available at:https://covidtracking.com/analysis-updates/what-we-know-about-the-impact-of-the-pandemic-on-our-most-vulnerable-community. Accessed July 12th 2021.

3. Effectiveness of Pfizer‐BioNTech and Moderna vaccines in preventing SARS‐CoV‐2 infection among nursing home residents before and during widespread circulation of the SARS‐CoV‐2 B.1.617.2 (Delta) variant ‐ National Healthcare Safety Network, march 1‐august 1, 2021;Nanduri S;MMWR Morb Mortal Wkly Rep,2021

4. Serological survey following SARS-COV-2 outbreaks at long-term care facilities in metro Vancouver, British Columbia: Implications for outbreak management and infection control policies

5. Using Serologic Testing to Assess the Effectiveness of Outbreak Control Efforts, Serial Polymerase Chain Reaction Testing, and Cohorting of Positive Severe Acute Respiratory Syndrome Coronavirus 2 Patients in a Skilled Nursing Facility

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salivary immune responses after COVID-19 vaccination;PLOS ONE;2024-09-03

2. Saliva antiviral antibody levels are detectable but correlate poorly with serum antibody levels following SARS-CoV-2 infection and/or vaccination;Journal of Infection;2023-10

3. Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responses;Journal of Immunological Methods;2023-03

4. Vaccines for the Prevention of Coronavirus Disease 2019 in Older Adults;Infectious Disease Clinics of North America;2023-03

5. Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19;The Journal of Allergy and Clinical Immunology: In Practice;2023-01